Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT03344393
Brief Summary:
.The aim of this study is to identify the analgesic effect of intraoperative ketamine intravenous infusion on patients undergoing intestinal surgery and its effect on salivary cortisol and alpha amylase levels as indicator of its effect.
Detailed Description:
I- Group K (ketamine): 30 patients will receive intraoperative intravenous ketamine infusion.
II- Group C (control): 30 patients will receive intraoperative intravenous normal saline infusion.
Study:
NCT03344393
Study Brief:
Protocol Section:
NCT03344393